Andrew Taylor

Andrew Taylor has a diverse work experience in finance and accounting. Andrew is currently serving as the Chief Financial Officer & Company Secretary at PYC Therapeutics since April 2022. Before that, they worked at Emeco Group from 2015 to 2022, holding various roles including General Manager Finance, Financial Controller, and Group Accountant. Prior to Emeco Group, they worked at Amcom as a Group Financial Accountant from 2012 to 2015. Andrew also has experience at Norilsk Nickel as a Financial Accountant and at EY as a Senior Accountant from 2008 to 2012.

Andrew Taylor attended Wesley College, Perth from 1998 to 2005, but no degree or field of study information was provided for this period. Andrew then went on to The University of Western Australia from 2006 to 2008, where they obtained a Bachelor of Commerce (BCom) with a focus on Financial Accounting and Corporate Finance. From 2009 to 2012, Andrew attended Chartered Accountants Australia and New Zealand, but no degree or field of study information was provided for this period. In 2013 and 2014, they studied at Kaplan Online Higher Education and obtained a Graduate Diploma of Applied Finance with a concentration in Corporate Finance. Andrew is currently enrolled in the Australian Institute of Company Directors and is expected to complete their education there in 2023, but no specific degree or field of study information was provided.